APRE: Aprea Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-13 | Fell below 5% | LYTTON LAURENCE W | 3.20% | SEC |
Institutional ownership (Q2 2026)
27 institutions reported holding $2.07M of Aprea Therapeutics, Inc. on Form 13F (22 the quarter before). 7 opened a new position and 2 sold out. Shares held by institutions: +15%.
| Largest holders | Shares | Value |
|---|---|---|
| AIGH Capital Management LLC | 1,015,541 | $815K |
| Nantahala Capital Management, LLC | 411,520 | $330K |
| Vestal Point Capital, LP | 350,000 | $281K |
| SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $217K |
| RENAISSANCE TECHNOLOGIES LLC | 105,800 | $85K |
| GEODE CAPITAL MANAGEMENT, LLC | 74,869 | $60K |
| CITADEL ADVISORS LLC | 58,600 | $47K |
| BNP PARIBAS FINANCIAL MARKETS | 45,211 | $36K |
| DIADEMA PARTNERS LP | 44,907 | $36K |
| VANGUARD FIDUCIARY TRUST CO | 38,464 | $31K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.